| Dexamethasone | Approved Investigational Vet Approved | NR3C1 | 2908 |
upregulated | Dexamethasone results in increased expression of NR3C1 mRNA | 5q31.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NR3C2 | 4306 |
upregulated | Dexamethasone results in increased expression of NR3C2 mRNA | 4q31 | |
| Dexamethasone | Approved Investigational Vet Approved | NR4A3 | 8013 |
upregulated | Dexamethasone results in increased expression of NR4A3 mRNA | 9q22 | |
| Dexamethasone | Approved Investigational Vet Approved | NR6A1 | 2649 |
upregulated | Dexamethasone results in increased expression of NR6A1 mRNA | 9q33.3 | |
| Dexamethasone | Approved Investigational Vet Approved | NRCAM | 4897 |
upregulated | Dexamethasone results in increased expression of NRCAM mRNA | 7q31.1 | |
| Dexamethasone | Approved Investigational Vet Approved | NREP | 9315 |
downregulated | Dexamethasone results in decreased expression of NREP mRNA | 5q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | NSDHL | 50814 |
upregulated | Dexamethasone results in increased expression of NSDHL mRNA | Xq28 | |
| Dexamethasone | Approved Investigational Vet Approved | NTM | 50863 |
downregulated | Dexamethasone results in decreased expression of NTM mRNA | 11q25 | |
| Dexamethasone | Approved Investigational Vet Approved | NUCB2 | 4925 |
downregulated | Dexamethasone results in decreased expression of NUCB2 mRNA | 11p15.1 | |
| Dexamethasone | Approved Investigational Vet Approved | NXPH4 | 11247 |
downregulated | Dexamethasone results in decreased expression of NXPH4 mRNA | 12q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | OARD1 | 221443 |
downregulated | Dexamethasone results in decreased expression of OARD1 mRNA | 6p21.1 | |
| Dexamethasone | Approved Investigational Vet Approved | OASL | 8638 |
upregulated | Dexamethasone results in increased expression of OASL mRNA | 12q24.31 | |
| Dexamethasone | Approved Investigational Vet Approved | OGFRL1 | 79627 |
upregulated | Dexamethasone results in increased expression of OGFRL1 mRNA | 6q13 | |
| Dexamethasone | Approved Investigational Vet Approved | OLFM4 | 10562 |
upregulated | Dexamethasone results in increased expression of OLFM4 mRNA | 13q14.3 | |
| Dexamethasone | Approved Investigational Vet Approved | OSBPL10 | 114884 |
downregulated | Dexamethasone results in decreased expression of OSBPL10 mRNA | 3p23 | |
| Dexamethasone | Approved Investigational Vet Approved | OSR2 | 116039 |
upregulated | Dexamethasone results in increased expression of OSR2 mRNA | 8q22.2 | |
| Dexamethasone | Approved Investigational Vet Approved | P3H2 | 55214 |
downregulated | Dexamethasone results in decreased expression of P3H2 mRNA | 3q28 | |
| Dexamethasone | Approved Investigational Vet Approved | P4HA2 | 8974 |
downregulated | Dexamethasone results in decreased expression of P4HA2 mRNA | 5q31.1 | |
| Dexamethasone | Approved Investigational Vet Approved | PAFAH1B3 | 5050 |
downregulated | Dexamethasone results in decreased expression of PAFAH1B3 mRNA | 19q13.1 | |
| Dexamethasone | Approved Investigational Vet Approved | PALLD | 23022 |
upregulated | Dexamethasone results in increased expression of PALLD mRNA | 4q32.3 | |
| Dexamethasone | Approved Investigational Vet Approved | PALM2-AKAP2 | 445815 |
upregulated | Dexamethasone results in increased expression of PALM2-AKAP2 mRNA | 9q31.3 | |
| Dexamethasone | Approved Investigational Vet Approved | PAMR1 | 25891 |
downregulated | Dexamethasone results in decreased expression of PAMR1 mRNA | 11p13 | |
| Dexamethasone | Approved Investigational Vet Approved | PAPPA | 5069 |
downregulated | Dexamethasone results in decreased expression of PAPPA mRNA | 9q33.1 | |
| Dexamethasone | Approved Investigational Vet Approved | PCK1 | 5105 |
upregulated | Dexamethasone results in increased expression of PCK1 mRNA | 20q13.31 | |
| Dexamethasone | Approved Investigational Vet Approved | PCYT2 | 5833 |
upregulated | Dexamethasone results in increased expression of PCYT2 mRNA | 17q25.3 | |